Diagnosis

Rheumatoid arthritis

A chronic systemic autoimmune disease characterized by persistent symmetric bilateral polyarthritis (synovitis) that usually affects the hands and feet (may affect other joints) and extra-articular involvement (skin, heart, lungs, and eyes).

Etiology

Cause [ud4]

Pathophysiology

  1. Autoantibodies --> Inflammation

    • CD4 T cells, mononuclear phagocytes, fibroblasts, osteoclasts, neutrophils, B cells (RF), TNF-alpha, IL-1, IL-6, IL-8, TGF-ß, FGF, and PDGF

  2. Arthritis --> synovial cell hyperplasia and cartilage/bone/tendon/ligament destruction

  3. Chronic arthritis --> loss of cartilage and bone erosions

  4. Distribution:

    • Joints: MCP, wrist, PIP, knee, MTP, shoulder, ankle, cervical spine, hip, elbow), synovial hypertrophy (pannus)

    • Extra-articular manifestations: Skin, heart, lungs, GI, vascular, hematologic, neurologic and eyes

Risk factors [rtx]

Complications [ud4]

Epidemiology

Incidence per 100.000 [onp][kqf][nm8][zme][qbc]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Arthralgia, Arthritis, Fever, Keratoconjunctivitis sicca, Malaise, Muscle atrophy, Polyarthritis, Stiffness, Weakness

Clinical findings

ANA, Anemia, Ankylosis, Anti-CCP, Anti-MCV, Bone erosion, Carpal Tunnel Syndrome, Elevated CRP, Elevated Sedimentation Rate, Hydrops, Joint effusion, Leukocytosis, Osteoporosis, Pericardial effusion, Rheumatoid factor, Tenosynovitis, Thrombocytosis, Ulnar deviation

Anamneses

None listed.

Localized findings

Pain
Radiates
JointsArmBackLower body
Onset
Subacute (hours)Gradual (days)
Pattern
ConstantIntermittentRecurring
Provoked by
Activity
Quality
AchingGnawing
Severity
Mild (1-3)Moderate (4-7)
Rash
Radiates
ArmLower body
Distribution
LocalizedMultipleSymmetric
Lesion type
NodulePurpuraUlcer
Palpation
Firm
Rash
Radiates
ArmHand
Distribution
Symmetric
Lesion type
Erythema
Color
Red
Palpation
Blanching
Swelling
Radiates
Joints
Onset
Gradual (days)
Pattern
Constant

Approach

Diagnostic criteria: 2010 ACR/EULAR Classification Criteria [rtx][ud4]

  1. Joint involvement:

    • 2-10 large joints = 1 point

    • 1-3 small joints (MCP, PIP, wrist joints) = 2 points

    • 4-10 small joints = 3 points

    • >10 joints = 5 points

  2. Serology test results:

    • Low-positive RF or low-positive anti-CCP = 2 points

    • High-positive RF or high-positive anti-CCP = 3 points

  3. Acute-phase reactant test results: Elevated CRP or ESR = 1 point

  4. Duration of signs and symptoms: >6 weeks = 1 point

Score of ≥6 is classified as definite RA

Treatment

  1. Conservative nonpharmacologic, nonsurgical therapies: [rtx]

    • Heat and cold therapies

    • Orthotics and splints

    • Therapeutic exercise

    • Occupational therapy

    • Adaptive equipment

    • Joint-protection education

    • Energy-conservation education

  2. Nonbiologic disease-modifying antirheumatic drugs (DMARDs): [rtx]

    • Hydroxychloroquine

    • Azathioprine

    • Sulfasalazine

    • Methotrexate

    • Leflunomide

    • Cyclosporine

    • Gold salts

    • D-penicillamine

    • Minocycline

  3. Biologic tumor necrosis factor (TNF)–inhibiting DMARDs: [rtx]

    • Etanercept

    • Infliximab

    • Adalimumab

    • Certolizumab

    • Golimumab

  4. Biologic non-TNF DMARDs include the following: [rtx]

    • Rituximab

    • Anakinra

    • Abatacept

    • Tocilizumab

    • Sarilumab

    • Tofacitinib

    • Baricitinib

    • Upadacitinib

  5. Other drugs used therapeutically include the following: [rtx]

    • Corticosteroids

    • Nonsteroidal anti-inflammatory drugs (NSAIDs)

    • Analgesics

  6. Surgical treatments include the following: [rtx]

    • Synovectomy

    • Tenosynovectomy

    • Tendon realignment

    • Reconstructive surgery or arthroplasty

    • Arthrodesis

Differential diagnoses

Carpal tunnel syndrome, Episcleritis, Fibromyalgia, Gout, Juvenile rheumatoid arthritis, Lyme disease, Osteoarthritis, Osteoporosis, Polymyalgia rheumatica, Psoriatic arthritis, Pyoderma gangrenosum, Reactive arthritis, Rheumatic fever, Sarcoidosis, Septic arthritis, Sjogren syndrome, Systemic lupus erythematosus, Uveitis


References

[1] Chauhan K, Jandu JS, Brent LH, et al. Rheumatoid Arthritis. [Updated 2023 May 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441999/

[2] http://emedicine.medscape.com/article/331715 (2014-01-27); [Medscape]

[3] Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol. 1980 Jan;111(1):87-98.

[4] Shi W, Liang X, Zhang H, Li H. Burden of rheumatoid arthritis in India from 1990 to 2021: insights from the Global Burden of Disease Database. Front Med (Lausanne). 2025 Feb 14;12:1526218.

[5] Lee H, Lee SI, Lim H, Kim HO, Kim RB, Cheon YH. Incidence Trends of Rheumatoid Arthritis in Korea for 11 Years (2006-2017). Clin Pract. 2024 Nov 13;14(6):2475-2483.

[6] Hanova P, Pavelka K, Dostal C, Holcatova I, Pikhart H. Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003. Clin Exp Rheumatol. 2006 Sep-Oct;24(5):499-507.

[7] Lai CH, Lai MS, Lai KL, Chen HH, Chiu YM. Nationwide population-based epidemiologic study of rheumatoid arthritis in Taiwan. Clin Exp Rheumatol. 2012 May-Jun;30(3):358-63.

Scroll to top